共 10 条
- [1] Kavuk I., Yavuz A., Cetindere U., Agelink M.W., Diener H.C., Epidemiology of chronic daily headache, Eur. J. Med. Res., 8, pp. 236-240, (2003)
- [2] Tomkins G.E., Jackson J.L., O'Malley P.G., Balden E., Santoro J.E., Treatment of chronic headache with antidepressants: A meta-analysis, Am. J. Med., 111, pp. 54-63, (2001)
- [3] Gomersall J.D., Stuart A., Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial, J. Neurol. Neurosurg. Psychiatry, 36, pp. 684-690, (1973)
- [4] Couch J.R., Hassanein R.S., Amitriptyline in migraine prophylaxis, Arch. Neurol., 36, pp. 695-699, (1979)
- [5] Ziegler D.K., Hurwitz A., Hassanein R.S., Kodanaz H.A., Preskorn S.H., Mason J., Migraine prophylaxis. A comparison of propranolol and amitriptyline, Arch. Neurol., 44, pp. 486-489, (1978)
- [6] Mathew N.T., Prophylaxis of migraine and mixed headache. A randomized controlled study, Headache, 21, pp. 105-109, (1981)
- [7] Pariante C.M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A.H., Kerwin R.W., Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters, Br. J. Pharmacol., 134, pp. 1335-1343, (2001)
- [8] Watanabe Y., Saito H., Abe K., Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices, Neuropharmacology, 32, pp. 479-486, (1993)
- [9] D'Amato C.C., Pizza V., Marmolo T., Giordano E., Alfano V., Nasta A., Fluoxetine for migraine prophylaxis: A double-blind trial, Headache, 39, pp. 716-719, (1999)
- [10] Bendtsen L., Jensen R., Olesen J., A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache, J. Neurol. Neurosurg. Psychiatry, 61, pp. 285-290, (1996)